POSA197 Modeled Impact of Nirsevimab Against Respiratory Syncytial Virus (RSV) Among UK Infants Experiencing Their First RSV Season

Autor: Beuvelet, M, Davidson, C, Hudson, R, Kieffer, A
Zdroj: In Value in Health January 2022 25(1) Supplement:S125-S125
Databáze: ScienceDirect